• TAK1-Mediated YAP Stabilization Drives Gastric Cancer Stemne

  2026-04-25

  This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP) to drive self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The findings provide critical mechanistic insight into GCSC maintenance and suggest new targets for therapeutic intervention in gastric cancer.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision Tools for mRNA Deliv

  2026-04-24

  ARCA Cy5 EGFP mRNA (5-moUTP) from APExBIO sets a new standard for fluorescent tracking of mRNA delivery, localization, and translation in mammalian cells. Its unique 5-methoxyuridine modification enables robust innate immune suppression and high-fidelity expression, empowering researchers to optimize workflows and troubleshoot delivery bottlenecks with direct, quantifiable readouts.

• Enhancing Tissue Morphology Visualization with H&E Staining

  2026-04-24

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) streamlines reliable tissue morphology visualization, supporting both paraffin and frozen section studies. Its ready-to-use solutions accelerate workflows and ensure consistent nuclear and cytoplasmic contrast, making it an essential tool for advanced histopathological tissue staining and experimental troubleshooting.

• Amiloride (MK-870): Mechanistic Leverage for Translational R

  2026-04-23

  Explore how Amiloride (MK-870) advances translational sodium channel and cellular uptake research. This article bridges mechanistic understanding with strategic deployment, contextualizes recent inhibitor evidence, and provides actionable protocol guidance.

• Berberine Hydrochloride: Protocol Advances for Metabolic Res

  2026-04-23

  Berberine Hydrochloride from APExBIO empowers metabolic, inflammation, and cancer assays with robust AMPK activation and precise inflammasome modulation. This guide details optimized workflows and troubleshooting strategies, enabling superior reproducibility and translational insights in diabetes, AKI, and cardiovascular studies.

• DNA Damage Sensing, TP53, and Sensitivity to Calicheamicin A

  2026-04-22

  This study systematically identifies DNA damage response genes, particularly TP53, ATM, and MDM2, as critical modulators of acute leukemia cell sensitivity to calicheamicin-based antibody–drug conjugates. The findings clarify resistance mechanisms and support the rational development of combination therapies targeting these pathways.

• DAPI Solution (1 mg/mL): Applied Workflows for Apoptosis Det

  2026-04-22

  DAPI Solution (1 mg/mL) from APExBIO enables precise nuclear visualization and robust apoptosis detection, especially in fixed or compromised cells. This article delivers hands-on protocol guidance, evidence-backed troubleshooting, and workflow integration insights for IDD and cell senescence models.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist in RA

  2026-04-21

  Coumestrol stands out as a dual-action tool in selective estrogen receptor modulator (SERM) studies, enabling both classic nuclear receptor antagonism and advanced ferroptosis-driven inflammation models. Its precision in modulating fibroblast-like synoviocyte behavior positions it as an essential reagent for dissecting complex endocrine and autoimmune pathways.

• Cy5.5 NHS Ester (Non-Sulfonated): Properties, Protocols, and

  2026-04-21

  Cy5.5 NHS ester (non-sulfonated) is a near-infrared fluorescent dye used for covalent labeling of biomolecules. Its high extinction coefficient and optimized NHS chemistry enable sensitive imaging, including in vivo tumor visualization. This dossier details its mechanism, validated parameters, and application limits.

• ECL Western Blotting Substrate: Technical Guide and Best Pra

  2026-04-20

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting HRP-conjugated proteins via chemiluminescence in Western blot assays. It is best suited for workflows in molecular biology, cancer biology, and signal transduction research where high signal-to-noise and reprobing are required, but should not be used for fluorescent or radioisotopic detection.

• G-1 (CAS 881639-98-1): Selective GPR30 Agonist in Neuropathi

  2026-04-20

  Explore how G-1, a selective GPR30 agonist, enables advanced interrogation of pain circuitry and estrogen receptor signaling. This article uniquely examines its role in neuropathic pain models, bridging receptor biology and translational assay design.

• Grazoprevir Hydrate: Precision Inhibition of HCV Replication

  2026-04-19

  Grazoprevir hydrate (MK-5172 hydrate) delivers picomolar potency against HCV, enabling robust replication inhibition even in complex patient-derived or co-infection models. This article details optimized workflows, troubleshooting, and comparative advantages for research and therapeutic applications, with actionable insights for advanced hepatitis C studies.

• DIDS: Mechanisms and Benchmarks for Chloride Channel Inhibit

  2026-04-18

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) is a potent anion transport inhibitor with validated effects on chloride channels and tumor models. It offers quantified selectivity for ClC-Ka and ClC-ec1 inhibition, modulates vascular and neuroprotective pathways, and supports mechanistic oncology workflows. Evidence-based parameters and clear solubility protocols ensure reproducibility for advanced research.

• (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

  2026-04-17

  (S)-(+)-Dimethindene maleate provides selective, dual antagonism at the M2 muscarinic acetylcholine and histamine H1 receptors, enabling precise interrogation of autonomic, cardiovascular, and respiratory signaling pathways. This product is suitable for receptor selectivity studies, but is not intended for diagnostic or medical applications. Adherence to recommended storage and handling is essential to maintain reagent integrity.

• Enhanced Intranasal mRNA Delivery via Muco-Penetrating iLLNs

  2026-04-16

  This article reviews a recent study introducing ionizable liquid lipid nanoparticles (iLLNs) for improved intranasal delivery of mRNA across the airway mucus barrier. The findings highlight increased reporter gene expression and mucosal immune responses, offering new directions for nasal mRNA vaccine development.

16072 records 1/1072 page Next 12345 下5页 Last page